Foundation expands its research reviewing body to meet strategic research investment objective NEW YORK, NY (April 30, 2024) – The Lung Cancer Research Foundation (LCRF) has expanded its Scientific Advisory Board (SAB) by five new members. Led by Katerina Politi, PhD, Associate Professor of Pathology and Internal Medicine, Yale School of Medicine, the Scientific Advisory Board’s primary purpose is to review, evaluate and select lung cancer research proposals worthy of financial investment. In addition, members of the SAB provide opinion and guidance on relevant lung cancer data. “We are honor ..read more

By Joanne Gaget April 2024 So how did I get lung cancer? Well, if you’re a lung cancer patient like me, I’m certain that this all too common question has played over and over in your mind as well; much like an endless repeat of a badly broken record (and yes, in light of today’s technology I am unabashedly dating myself here)! Walking back through the last six decades of my life, I reflected on the remarkable strength of my respiratory system and the fact that I never had a cough…except when I contracted the first variant of Covid in 2020. Oh and yes, there was that one time I had bronchitis ..read more

Patients, caregivers, and others interested in lung cancer research gathered at The RiverMarket Kitchen and Bar in Tarrytown, NY on April 13 to hear about the latest developments and important topics in lung cancer. LCRF Together New York offered an opportunity for the community to connect while learning about promising therapies for treatment. Brendon Stiles, MD, and Balazs Halmos, MD, MS, from Montefiore Einstein Comprehensive Cancer Center had a lively discussion with the group and moderator Isabel Preeshagul, DO, MBS, Memorial Sloan Kettering Cancer Center. Dr. Stiles is the Vice Cha ..read more

April 2024 Caroline with her boys Caroline, a nurse practitioner who lives in Louisiana, was more familiar with lung cancer than she cared to be. “About 15 years ago, my maternal aunt was diagnosed with stage 4 lung cancer – in her 40s – and died a year later. And she was a never smoker, very healthy,” she explained. “We all thought, ‘okay, that’s random.’ Fast forward to 2021, my maternal grandmother was also diagnosed with stage 4 lung cancer. Another never smoker. Thankfully, my grandmother lives in Houston and got into MD Anderson. They mentioned the EGFR mutation, so she got tested and w ..read more

For our April #TogetherSeparately livestream talk, Julia Rotow, MD, and Isabel Preeshagul, DO, MBS, discussed resources available to patients and caregivers, assembling and managing a care team, and questions to ask at appointments. Dr. Rotow is Clinical Director, Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, and Assistant Professor of Medicine, Harvard Medical School. Watch the recording below. The post #TogetherSeparately: Lung Cancer from Day 1 and Beyond appeared first on Lung Cancer Research Foundation ..read more

The good news The FDA recently granted approval to tepotinib for the treatment of advanced non-small cell lung cancer (NSCLC) with MET exon 14 skipping alterations. Why it’s important MET alterations occur in 3-4% of patients with NSCLC, and those alterations are responsible for driving the development of the cancer. Patients who have MET exon 14 skipping alterations are typically older individuals at 70 years or greater. The Vision trial was a Phase 2 study that evaluated tepotinib in different groups of patients. In those with exon 14 skipping alterations who were not previously treated, 5 ..read more

Meet the newest member of LCRF’s science team, and hear a quick update on the foundation’s research program as well as news from the lung cancer space. Watch the video below. Featured: Aubrey Rhodes, LCRF Executive Director Dhru Deb, PhD, Senior Director, Research & Administration Antoinette (Toni) Wozniak, MD, Chief Scientific Officer The post Science UpdateSpring 2024 appeared first on Lung Cancer Research Foundation ..read more

By Jeff Stibelman March 2024 I was first diagnosed with cancer of the cervical spine on January 1, 2017, after experiencing very severe nerve pain down my whole right side. Thankfully, due to the sensitivity of what was to be my operation, my doctor sent me to one of the best surgeons in the country at USC Keck MD Center, LA, California. At that time I was told in the beginning it was a schwannoma, a non-cancerous lesion, but it was on my main nerve, hence the excruciating pain, affecting my whole right side. I had to wait for weeks with a lot of pain, since they thought it was benign. I fina ..read more

Foundation honors Mark G. Kris, MD NEW YORK, NY (April 2, 2024) – The Lung Cancer Research Foundation (LCRF) is pleased to announce Dr. Mark G. Kris as its honoree for the 3rd annual Evening of Innovation Gala, which will be held on September 24, 2024 at the Metropolitan Club in Manhattan. Members of LCRF’s Board of Directors and Gala Committee are committed to showcasing LCRF’s impact through recognition of an individual whose support of the organization and the field of lung cancer research is unparalleled, and someone who exemplifies the spirit of LCRF to improve the lives of persons with ..read more

March 30 is National Doctors’ Day, and once again we invited you to send thank you messages to the physicians who have made a difference in your life. Here are a few of the kudos you shared with your inspiring doctors! Thank you to doctors everywhere who are using the results of lung cancer research to give their patients better, longer lives. It’s never too late to support research in honor of your own doctor. Make your own tribute here. To Mohamed Mohamed, MD, Wesley Long Cancer Center “Thank you, Dr. M, for taking this difficult journey with me, being sensitive to my needs, while still ..read more